Amgen Inc. buy BMO Capital Markets
Start price
03.12.25
/
50%
€288.65
Target price
03.12.26
-
Performance (%)
23.54%
Price
13:43
€351.55
Summary
This prediction is currently active. The prediction currently has a performance of 23.54%. A total of €5.04 was paid as dividends for this prediction. This prediction currently runs until 03.12.26. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amgen Inc. | 4.520% | 4.520% |
| iShares Core DAX® | 1.842% | 1.387% |
| iShares Nasdaq 100 | 4.659% | -1.797% |
| iShares Nikkei 225® | 3.963% | -5.216% |
| iShares S&P 500 | 3.700% | 1.576% |
Comments by BMO_Capital_Markets for this prediction
In the thread Amgen Inc. diskutieren
Amgen (NASDAQ:AMGN) had its "outperform" rating reaffirmed by analysts at BMO Capital Markets.
Ratings data for AMGN provided by MarketBeat